help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, Y.-H.
Right arrow Articles by Maurer, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, Y.-H.
Right arrow Articles by Maurer, R. A.
Molecular Endocrinology 13 (7): 1094-1104
Copyright © 1999 by The Endocrine Society

A Role for the Mitogen-Activated Protein Kinase in Mediating the Ability of Thyrotropin-Releasing Hormone to Stimulate the Prolactin Promoter

Ying-Hong Wang and Richard A. Maurer

Department of Cell and Developmental Biology Oregon Health Sciences University Portland, Oregon 97201

The hypothalamic hormone, TRH, stimulates PRL secretion and gene transcription. We have examined the possibility that the mitogen-activated protein kinase (MAPK) may play a role in mediating TRH effects on the PRL gene. TRH was found to stimulate sustained activation of MAPK in PRL-producing, GH3 cells, consistent with a possible role in transcriptional regulation. A kinase-defective, interfering MAPK kinase (MAPKK) mutant reduced TRH induction of the PRL promoter. Treatment with the MAPKK inhibitor, PD98059, blocked TRH-induced activation of MAPK and also reduced TRH induction of a PRL-luciferase reporter gene, confirming that MAPK activation is necessary for TRH effects on PRL gene expression. Previous studies have demonstrated that the PRL promoter contains binding sites for members of the Ets family of transcription factors, which are important for mediating MAPK responsiveness of the PRL promoter. Mutation of specific Ets sites within the PRL promoter reduced responsiveness to both TRH and MAPK. The finding that DNA elements required for MAPK responsiveness of the PRL gene colocalize with DNA elements required for TRH responsiveness further supports a role for MAPK in mediating TRH effects on the PRL gene. We also explored the signaling mechanisms that link the TRH receptor to MAPK induction. Occupancy of the TRH receptor results in activation of protein kinase C (PKC) as well as increases in the concentration of Ca2+ due to release from intracellular stores and entry of Ca2+ through Ca2+ channels. A PKC inhibitor, GF109203X, and an L-type Ca2+ channel blocker, nimodipine, both partially reduced TRH-induced MAPK activation and PRL promoter activity. The effects of the two inhibitors were additive. These studies are consistent with a signaling pathway involving PKC- and Ca2+-dependent activation of MAPK, which leads to phosphorylation of an Ets transcription factor and activation of the PRL promoter.




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
H. Nafisi, B. Banihashemi, M. Daigle, and P. R. Albert
GAP1(IP4BP)/RASA3 Mediates G{alpha}i-induced Inhibition of Mitogen-activated Protein Kinase
J. Biol. Chem., December 19, 2008; 283(51): 35908 - 35917.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
A. M. Lopez-Dominguez, J. L. Espinosa, A. Navarrete, G. Avila, and G. Cota
Nerve growth factor affects Ca2+ currents via the p75 receptor to enhance prolactin mRNA levels in GH3 rat pituitary cells
J. Physiol., July 15, 2006; 574(2): 349 - 365.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. Yamada, N. Shibusawa, S. Ishii, K. Horiguchi, R. Umezawa, K. Hashimoto, T. Monden, T. Satoh, J. Hirato, and M. Mori
Prolactin Secretion in Mice with Thyrotropin-Releasing Hormone Deficiency
Endocrinology, May 1, 2006; 147(5): 2591 - 2596.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
J. C. Liu, R. E. Baker, W. Chow, C. K. Sun, and H. P. Elsholtz
Epigenetic Mechanisms in the Dopamine D2 Receptor-Dependent Inhibition of the Prolactin Gene
Mol. Endocrinol., July 1, 2005; 19(7): 1904 - 1917.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. Romano, K. Magalon, A. Ciampini, C. Talet, A. Enjalbert, and C. Gerard
Differential Involvement of the Ras and Rap1 Small GTPases in Vasoactive Intestinal and Pituitary Adenylyl Cyclase Activating Polypeptides Control of the Prolactin Gene
J. Biol. Chem., December 19, 2003; 278(51): 51386 - 51394.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. E. Schweppe, A. A. Melton, K. S. Brodsky, L. D. Aveline, K. A. Resing, N. G. Ahn, and A. Gutierrez-Hartmann
Purification and Mass Spectrometric Identification of GA-binding Protein (GABP) as the Functional Pituitary Ets Factor Binding to the Basal Transcription Element of the Prolactin Promoter
J. Biol. Chem., May 2, 2003; 278(19): 16863 - 16872.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Lania, M. Filopanti, S. Corbetta, M. Losa, E. Ballare, P. Beck-Peccoz, and A. Spada
Effects of Hypothalamic Neuropeptides on Extracellular Signal-Regulated Kinase (ERK1 and ERK2) Cascade in Human Tumoral Pituitary Cells
J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1692 - 1696.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
B. Banihashemi and P. R. Albert
Dopamine-D2S Receptor Inhibition of Calcium Influx, Adenylyl Cyclase, and Mitogen-Activated Protein Kinase in Pituitary Cells: Distinct G{alpha} and G{beta}{gamma} Requirements
Mol. Endocrinol., October 1, 2002; 16(10): 2393 - 2404.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. C. Liu, R. E. Baker, C. Sun, V. C. Sundmark, and H. P. Elsholtz
Activation of Go-coupled Dopamine D2 Receptors Inhibits ERK1/ERK2 in Pituitary Cells. A KEY STEP IN THE TRANSCRIPTIONAL SUPPRESSION OF THE PROLACTIN GENE
J. Biol. Chem., September 20, 2002; 277(39): 35819 - 35825.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
C. Villalobos, L. Nunez, W. J. Faught, D. C. Leaumont, F. R. Boockfor, and L. S. Frawley
Calcium Dynamics and Resting Transcriptional Activity Regulates Prolactin Gene Expression
Endocrinology, September 1, 2002; 143(9): 3548 - 3554.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
P. R. Albert
G Protein Preferences for Dopamine D2 Inhibition of Prolactin Secretion and DNA Synthesis in GH4 Pituitary Cells
Mol. Endocrinol., August 1, 2002; 16(8): 1903 - 1911.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
H. Kanasaki, T. Yonehara, H. Yamamoto, Y. Takeuchi, K. Fukunaga, K. Takahashi, K. Miyazaki, and E. Miyamoto
Differential Regulation of Pituitary Hormone Secretion and Gene Expression by Thyrotropin-Releasing Hormone. A Role for Mitogen-Activated Protein Kinase Signaling Cascade in Rat Pituitary GH3 Cells
Biol Reprod, July 1, 2002; 67(1): 107 - 113.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
P. R. Albert
Editorial: Dopamine-D2-Mediated Inhibition of TRH-Induced PLC Activation in Pituitary Cells--Direct or Indirect?
Endocrinology, March 1, 2002; 143(3): 744 - 746.
[Full Text] [PDF]

Home page
 EndocrinologyHome page
J. Hayakawa, M. Ohmichi, K. Tasaka, Y. Kanda, K. Adachi, Y. Nishio, K. Hisamoto, S. Mabuchi, S. Hinuma, and Y. Murata
Regulation of the PRL Promoter by Akt through cAMP Response Element Binding Protein
Endocrinology, January 1, 2002; 143(1): 13 - 22.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
T. A. Jackson, R. E. Schweppe, D. M. Koterwas, and A. P. Bradford
Fibroblast Growth Factor Activation of the Rat PRL Promoter is Mediated by PKC{delta}
Mol. Endocrinol., September 1, 2001; 15(9): 1517 - 1528.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
J. Smith, R. Yu, and P. M. Hinkle
Activation of MAPK by TRH Requires Clathrin-Dependent Endocytosis and PKC but Not Receptor Interaction with {beta}-Arrestin or Receptor Endocytosis
Mol. Endocrinol., September 1, 2001; 15(9): 1539 - 1548.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J.-H. Cho, H. Kimura, T. Minami, J. Ohgane, N. Hattori, S. Tanaka, and K. Shiota
DNA Methylation Regulates Placental Lactogen I Gene Expression
Endocrinology, August 1, 2001; 142(8): 3389 - 3396.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
P. Kievit, J. D. Lauten, and R. A. Maurer
Analysis of the Role of the Mitogen-Activated Protein Kinase in Mediating Cyclic-Adenosine 3',5'-Monophosphate Effects on Prolactin Promoter Activity
Mol. Endocrinol., April 1, 2001; 15(4): 614 - 624.
[Abstract] [Full Text]

Home page
 Nucleic Acids ResHome page
R. E. Schweppe and A. Gutierrez-Hartmann
Pituitary Ets-1 and GABP bind to the growth factor regulatory sites of the rat prolactin promoter
Nucleic Acids Res., March 1, 2001; 29(5): 1251 - 1260.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
Y.-H. Wang, S. F. Jue, and R. A. Maurer
Thyrotropin-Releasing Hormone Stimulates Phosphorylation of the Epidermal Growth Factor Receptor in GH3 Pituitary Cells
Mol. Endocrinol., September 1, 2000; 14(9): 1328 - 1337.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
A. P. Bradford, K. S. Brodsky, S. E. Diamond, L. C. Kuhn, Y. Liu, and A. Gutierrez-Hartmann
The Pit-1 Homeodomain and beta -Domain Interact with Ets-1 and Modulate Synergistic Activation of the Rat Prolactin Promoter
J. Biol. Chem., February 4, 2000; 275(5): 3100 - 3106.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society